These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4151316)

  • 1. Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection.
    Fibiger HC; Phillips AG; Zis AP
    Pharmacol Biochem Behav; 1974; 2(1):87-96. PubMed ID: 4151316
    [No Abstract]   [Full Text] [Related]  

  • 2. Discriminated escape learning and response to electric shock after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection.
    Price MT; Fibiger HC
    Pharmacol Biochem Behav; 1975; 3(2):285-90. PubMed ID: 1096176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal by L-dopa of impaired learning due to destruction of the dopaminergic nigro-neostriatal projection.
    Zis AP; Fibiger HC; Phillips AG
    Science; 1974 Sep; 185(4155):960-2. PubMed ID: 4471715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: similarities to the lateral hypothalamic syndrome.
    Fibiger HC; Zis AP; McGeer EG
    Brain Res; 1973 May; 55(1):135-48. PubMed ID: 4145913
    [No Abstract]   [Full Text] [Related]  

  • 5. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of 6-hydroxydopamine on the nature of proteins undergoing axoplasmic transport in nigro-neostriatal neurons.
    Singh VK; Fibiger HC; McGeer PL
    J Neurochem; 1974 Sep; 23(3):601-4. PubMed ID: 4153672
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specificity of the effect on the avoidance conditionning of microinjections of 6-hydroxydopamine in rat nigro-striatal system].
    Echavarria-Mage MT; Senault B; Delacour J
    C R Acad Hebd Seances Acad Sci D; 1976 Mar; 282(9):905-7. PubMed ID: 820478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of avoidance performance by intrastriatal administration of 6-hydroxydopamine.
    Neill DB; Boggan WO; Grossman SP
    Pharmacol Biochem Behav; 1974; 2(1):97-103. PubMed ID: 4597522
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity of avoidance deficits produced by 6-hydroxydopamine lesions of the nigrostriatal system of the rat.
    Delacour J; Echavarria MT; Senault B; Houcine O
    J Comp Physiol Psychol; 1977 Aug; 91(4):875-85. PubMed ID: 893749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Hydroxydopamine and striatal acetylcholine levels.
    Grewaal DS; Fibiger HC; McGeer EG
    Brain Res; 1974 Jun; 73(2):372-5. PubMed ID: 4151550
    [No Abstract]   [Full Text] [Related]  

  • 12. Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat.
    Fibiger HC; Fibiger HP; Zis AP
    Br J Pharmacol; 1973 Apr; 47(4):683-92. PubMed ID: 4146741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine response in rat after dopamine neurone destruction.
    Creese I; Iversen SD
    Nat New Biol; 1972 Aug; 238(86):247-8. PubMed ID: 4404010
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebral amines and behavior. Central effects of 6-hydroxydopamine].
    Longo VG; Scotti de Carolis A
    Actual Pharmacol (Paris); 1973; 26(0):103-19. PubMed ID: 4367113
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacological and anatomical substrates of the amphetamine response in the rat.
    Creese I; Iversen SD
    Brain Res; 1975 Jan; 83(3):419-36. PubMed ID: 234270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine.
    Cooper BR; Howard JL; Grant LD; Smith RD; Breese GR
    Pharmacol Biochem Behav; 1974; 2(5):639-49. PubMed ID: 4610593
    [No Abstract]   [Full Text] [Related]  

  • 18. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of narcotic analgesics on the turning behaviour of rats with 6-hydroxydopamine-induced unilateral nigro-striatal lesions.
    Slater P; Blundell C; Crossman AR
    Neuropharmacology; 1980 Feb; 19(2):187-93. PubMed ID: 6102357
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system.
    Johnson M; Stone DM; Hanson GR; Gibb JW
    Eur J Pharmacol; 1987 Mar; 135(2):231-4. PubMed ID: 2884120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.